Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer
Clinical trial NCT02402712 · COMPLETED
Trial details
- NCT number
- NCT02402712
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-06
- Primary completion
- 2019-02-22
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.